Institutional Biosafety Committee
Appointed by the Provost
The Institutional Biosafety Committee (IBC) recommends policies and reviews protocols involving recombinant and/or synthetic nucleic acid molecules (rDNA); Risk Group 2 and 3 microorganisms; biological toxins; bloodborne pathogens; human and nonhuman primate materials; transgenic plants and animals; and mammalian tumor cell lines. Research protocols are reviewed for compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (“NIH Guidelines”); the Federal Select Agent Program; Biosafety in Microbiological and Biomedical Laboratories (BMBL); and the institutional biosafety manual. University researchers with projects involving any materials or processes subject to oversight must receive IBC approval before beginning their work.
Membership consists of five faculty members nominated by the Committee on Committees; one graduate student with a knowledge of rDNA research; two persons not affiliated with the University of Arkansas (apart from their membership on the committee) and not an immediate family member of anyone affiliated with the university, representing the interests of the surrounding community with respect to health and protection of the environment; a representative of the Pat Walker Health Center; and, ex officio and non-voting, the manager of the Office of Environmental Health and Safety or his/her designee, the IACUC Program Manager; and the Director of Research Compliance. The committee members shall collectively have expertise in rDNA, human pathogens, and transgenic plant and animal containment methodologies.
The provost designates a chairperson from the faculty members.
|Faculty at Large||2022|
|Bob Beitle||Faculty at Large||2023|
|Christian Tipsmark||Faculty at Large||2024|
|Martin Egan||Faculty at Large||2024|
|Young Min Kwon||Faculty at Large||2023|
|Brihget Sicairos-Meza||Graduate student||2022|
|Kayla Daniel||Community representative||2022|
|Malcolm Hayward||Community representative||2022|
|Carlos Acosta||Pat Walker Health Center||2023|
|James Hogan||Environmental Health and Safety Representative**|
|Rebecca Kavanaugh||IACUC Program Manager**|
|Shatara Porchia-White||Director of Research Integrity and Compliance**|
**=ex officio non-voting